Elevai Labs INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
PMGC Holdings Inc. announces the merger of its wholly owned subsidiaries, AGA Precision Systems LLC into A&B Aerospace, Inc., effective July 2, 2026.
NASDAQ
PMGC Holdings Inc. subsidiary NorthStrive Defense Tech LLC has secured an exclusive worldwide license for aerospace and defense technologies covered by U.S. Patent No. 12,291,334.
NASDAQ
NorthStrive Biosciences, a subsidiary of PMGC Holdings, announced positive Phase III results from its AI-driven drug discovery program with Yuva Biosciences, identifying four small-molecule candidates that increased ANT1 protein expression in human skeletal muscle cells.
NASDAQ
PMGC Holdings Inc. shareholders approved a staggered board structure and re-elected five directors at the 2026 Annual Meeting.
NASDAQ
PMGC Holdings' subsidiary NorthStrive Defense Tech has entered into an exclusive global licensing and research agreement with Florida State University for advanced aerospace and defense technology.
NASDAQ
PMGC Holdings Inc. has acquired A&B Aerospace, Inc., a precision machining and aerospace manufacturing company, as part of its roll-up strategy.
NASDAQ
PMGC Holdings Inc.'s subsidiary, NorthStrive Biosciences, announced the filing of a U.S. patent application for its EL-22 technology targeting muscle loss in human patients.
NASDAQ
PMGC Holdings' subsidiary, NorthStrive Defense Tech, has secured an option to license patented GPS-denied autonomous drone navigation technology.
NASDAQ
PMGC Holdings Inc. subsidiary SVM Machining has signed a long-term agreement to supply mission-critical components to Turbo-Jet Products Co., Inc., bolstering its presence in the aerospace and defense sector.
NASDAQ
PMGC Holdings Inc. has entered into a $40 million equity purchase facility to fund its aerospace and defense M&A strategy.
NASDAQ
AGA Precision Systems, a subsidiary of PMGC Holdings, announced a new Long-Term Agreement with a Tier 1 aerospace and defense firm, marking its second such deal in 2026.
NASDAQ
PMGC Holdings Inc. announced the full utilization of its $20 million equity financing facility, strengthening its cash position to advance a multi-sector acquisition strategy.
NASDAQ
PMGC Holdings subsidiary NorthStrive Defense Tech has acquired an exclusive option to license patent rights for a multi-domain drone system capable of air and water transport.
NASDAQ
PMGC Holdings' subsidiary, AGA Precision Systems, signed a long-term agreement to supply mission-critical aerospace and defense components to Turbo-Jet Products.
NASDAQ
PMGC Holdings Inc. subsidiary Northstrive Biosciences amended its license agreement with MOA Life Plus, updating drug development milestones and timelines, and agreeing to a one-time payment.
NASDAQ
PMGC Holdings Inc. announced its subsidiary, SVM Machining, Inc., has completed ITAR registration, opening doors to U.S. defense manufacturing contracts.
NASDAQ
PMGC Holdings Inc. has amended consulting agreements for its CEO and Chairman, setting annual fees at $300,000 and $360,000, respectively, effective January 1, 2026.
NASDAQ
PMGC Holdings Inc. (ELAB) finalized a $7.45 million secured pre-paid equity purchase, establishing a new subsidiary and granting a first-position security interest to the investor.
NASDAQ
NorthStrive Biosciences, a PMGC Holdings subsidiary, announced the filing of ten new U.S. patent applications for its EL-22 and EL-32 technologies, expanding into animal health and agricultural markets.
NASDAQ
Northstrive Biosciences, a PMGC Holdings subsidiary, has signed a definitive, exclusive license agreement with Modulant Biosciences for its EL-22 and EL-32 myostatin-engineered probiotics for animal health applications.
NASDAQ
PMGC Holdings Inc.'s subsidiary, Northstrive Biosciences, has entered into an exclusive, royalty-bearing license agreement with Modulant Biosciences LLC for the development and commercialization of animal health products worldwide, excluding Korea.
NASDAQ
PMGC Holdings Inc. has completed its third California-based CNC machine shop acquisition, SVM Machining, Inc., for a total purchase price of over $2.4 million, including potential earnouts.
NASDAQ
PMGC Holdings Inc. (ELAB) has entered into a third secured pre-paid equity purchase facility with Streeterville Capital, LLC, securing $5 million in initial funding.
NASDAQ
PMGC Holdings Inc. entered into a second secured pre-paid purchase agreement with an investor, securing $3 million in initial funding with an option for future equity conversions.
NASDAQ
PMGC Holdings Inc. announced a 4-for-1 reverse stock split, effective January 6, 2026, to consolidate its common stock.
NASDAQ
PMGC Holdings Inc. announced its subsidiary NorthStrive Biosciences initiated Phase III of an AI-driven drug discovery program and its subsidiary AGA Precision Systems LLC achieved AS9100 aerospace certification.
NASDAQ
PMGC Holdings Inc. announced the results of its Annual Meeting of Shareholders, where all director nominees were elected and the appointment of HTL International, LLC as auditor was ratified.
NASDAQ
PMGC Holdings Inc. announced its wholly owned subsidiary, AGA Precision Systems LLC, has received International Traffic in Arms Regulations (ITAR) registration, enabling expansion into defense and aerospace manufacturing.
NASDAQ
PMGC Holdings Inc.'s subsidiary, AGA Precision Systems LLC, has completed the acquisition of Indarg Engineering, Inc., a precision CNC machining company, for $548,000 to expand its aerospace and defense manufacturing platform.
NASDAQ
PMGC Holdings Inc. has amended consulting and secondment agreements with entities tied to its CEO and Non-Executive Chairman, clarifying roles, compensation, and authority.